Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Neurology|June 6, 2019
Natural course of scoliosis and lifetime risk of scoliosis surgery in spinal muscular atrophyCamiel A Wijngaarde, Rob C Brink, Floor A S de Kort, et al.Neurology|May 7, 2026
Lung Function and Respiratory Muscle Strength in Symptomatic Children and Adults With Spinal Muscular Atrophy Treated With NusinersenFemke Vercoelen, Lieke A P Arts, Marit E M de Bruijne, et al.Brain Communications|November 16, 2022
Population-based assessment of nusinersen efficacy in children with spinal muscular atrophy: a 3-year follow-up studyFéline E V Scheijmans, Inge Cuppen, Ruben P A van Eijk, et al.Neurology. Genetics|February 12, 2020
Analysis of FUS, PFN2, TDP-43, and PLS3 as potential disease severity modifiers in spinal muscular atrophyRenske I Wadman, Marc D Jansen, Chantall A D Curial, et al.Orphanet Journal of Rare Diseases|April 12, 2020
Natural history of lung function in spinal muscular atrophyCamiel A Wijngaarde, Esther S Veldhoen, Ruben P A van Eijk, et al.Orphanet Journal of Rare Diseases|February 22, 2022
Natural history of respiratory muscle strength in spinal muscular atrophy: a prospective national cohort studyEsther S Veldhoen, Camiel A Wijngaarde, Erik H J Hulzebos, et al.Iscience|May 19, 2025
Comprehensive analysis across SMN2 excludes DNA methylation as an epigenetic biomarker for spinal muscular atrophyMaria M Zwartkruis, Joris V Kortooms, Demi Gommers, et al.Orphanet Journal of Rare Diseases|February 24, 2023
Lung function decline preceding chronic respiratory failure in spinal muscular atrophy: a national prospective cohort studyEsther S Veldhoen, Camiel A Wijngaarde, Ruben P A van Eijk, et al.Brain Communications|January 12, 2023
Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2-4Marloes Stam, Camiel A Wijngaarde, Bart Bartels, et al.Journal of Neurology|October 29, 2013
Mapping the differences in care for 5,000 spinal muscular atrophy patients, a survey of 24 national registries in North America, Australasia and EuropeCatherine L Bladen, Rachel Thompson, Jacqueline M Jackson, et al.Pageof 5